Abstract
Background
NEC is a life-threatening gastrointestinal disease in neonates, the pathogenesis of which remains poorly understood.
Methods
CCL3 levels in intestinal tissue of mice were measured and analyzed. HE staining was used to assess pathological changes in intestinal tissue. FCM was used to detect the proportion and phenotype of macrophages. RNA-seq and RT-PCR were used to evaluate the effect of CCL3 on macrophages.
Results
CCL3 was highly expressed in the intestinal tissues of mice with NEC and induced macrophage infiltration. Transcriptome data showed that CCL3 strongly induced a transition in the phenotype of macrophages into a proinflammatory one. Mechanistically, in vivo experiments confirmed that CCL3 induced M1 macrophage polarization in NEC intestinal tissue, thereby aggravating inflammatory injury of intestinal tissue, which was alleviated by anti-CCL3 treatment. In addition, in vitro experiments showed that CCL3 significantly enhances the expression of M1-related genes in both PMφ and BMDM while inhibiting the expression of M2-related genes, which was also alleviated by anti-CCl3 treatment.
Conclusions
Our data elucidated the involvement of CCL3 in the pathogenesis of NEC, in which upregulated CCL3 expression exacerbated inflammatory intestinal damage by regulating macrophage chemotaxis and M1 phenotype polarization, suggesting that blocking CCL3 may be a potential strategy for effective intervention in NEC.
Impact
-
Our study represents an important conceptual advancement that CCL3 may be one of the key culprits of intestinal tissue damage in patients with NEC.
-
CCL3 aggravates inflammatory intestinal injury and intestinal mucosal barrier imbalance by regulating the chemotaxis, polarization, and function of macrophages.
-
Blocking CCL3 significantly reduced NEC-mediated intestinal injury, suggesting a new potential therapeutic strategy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
Neu, J. & Walker, W. A. Necrotizing enterocolitis. N. Engl. J. Med. 364, 255–264 (2011).
Frost, B. L. et al. New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr. 171, 83–88 (2017).
Ou, J. et al. Nutrition in necrotizing enterocolitis and following intestinal resection. Nutrients 12, 520 (2020).
Niño, D. F., Sodhi, C. P. & Hackam, D. J. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat. Rev. Gastroenterol. Hepatol. 13, 590–600 (2016).
Hunter, C. J. et al. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr. Res. 63, 117–123 (2008).
Reisinger, K. W. et al. Breast-feeding improves gut maturation compared with formula feeding in preterm babies. J. Pediatr. Gastroenterol. Nutr. 59, 720–724 (2014).
Heida, F. H. et al. Risk factors associated with postnecrotizing enterocolitis strictures in infants. J. Pediatr. Surg. 51, 1126–1130 (2016).
Amin, S. C. et al. Short bowel syndrome in the NICU. Clin. Perinatol. 40, 53–68 (2013).
Elfvin, A. et al. Low birthweight, gestational age, need for surgical intervention and gram-negative bacteraemia predict intestinal failure following necrotising enterocolitis. Acta Paediatr. 104, 771–776 (2015).
Collado, M. C. et al. Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infants. Pediatr. Res. 77, 726–731 (2015).
Good, M., Sodhi, C. P. & Hackam, D. J. Evidence-based feeding strategies before and after the development of necrotizing enterocolitis. Expert Rev. Clin. Immunol. 10, 875–884 (2014).
Zhou, Y. et al. Inflammation and apoptosis: dual mediator role for toll-like receptor 4 in the development of necrotizing enterocolitis. Inflamm. Bowel Dis. 23, 44–56 (2017).
MohanKumar, K. et al. Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G93–G102 (2012).
Wei, J. et al. Irf5 deficiency in myeloid cells prevents necrotizing enterocolitis by inhibiting M1 macrophage polarization. Mucosal Immunol. 12, 888–896 (2019).
Liu, X. et al. Geraniin inhibits LPS-induced THP-1 macrophages switching to M1 phenotype via SOCS1/NF-κB pathway. Inflammation 39, 1421–1433 (2016).
Wei, J. & Besner, G. E. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis. J. Surg. Res. 197, 126–138 (2015).
Deniffel, D. et al. Otitis media and nasopharyngeal colonization in mice. Infect. Immun. 85, e00148–17 (2017).
Russell, C. D. et al. The human immune response to respiratory syncytial virus infection. Clin. Microbiol. Rev. 30, 481–502 (2017).
Gibaldi, D. et al. CCL3/macrophage inflammatory protein-1α is dually involved in parasite persistence and induction of a TNF- and IFNγ-enriched inflammatory milieu in Trypanosoma cruzi-induced chronic cardiomyopathy. Front. Immunol. 11, 306 (2020).
Schaller, T. H. et al. Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. Expert Rev. Clin. Immunol. 13, 1049–1060 (2017).
Ishida, Y. et al. Prevention of CaCl-induced aortic inflammation and subsequent aneurysm formation by the CCL3-CCR5 axis. Nat. Commun. 11, 5994 (2020).
Koike, Y. et al. Remote ischemic conditioning counteracts the intestinal damage of necrotizing enterocolitis by improving intestinal microcirculation. Nat. Commun. 11, 4950 (2020).
Kovler, M. L., Sodhi, C. P. & Hackam, D. J. Precision-based modeling approaches for necrotizing enterocolitis. Dis. Model Mech. 13, dmm044388 (2020).
Allen, F. et al. CCL3 augments tumor rejection and enhances CD8(+) T cell infiltration through NK and CD103(+) dendritic cell recruitment via IFNγ. Oncoimmunology 7, e1393598 (2018).
Soares, D. M. et al. CCL3/MIP-1 alpha is not involved in the LPS-induced fever and its pyrogenic activity depends on CRF. Brain Res. 1269, 54–60 (2009).
Llorián-Salvador, M. et al. Involvement of CC chemokine receptor 1 and CCL3 in acute and chronic inflammatory pain in mice. Basic Clin. Pharm. Toxicol. 119, 32–40 (2016).
Yuan, X. et al. Novel therapeutic targeting of CCL3-CCR4 axis mediated apoptotic intesitnal injury in necrotizing enterocolitis. Front. Immunol. 13, 859398 (2022).
Pineda-Torra, I. et al. Isolation, culture, and polarization of murine bone marrow-derived and peritoneal macrophages. Methods Mol. Biol. 1339, 101–109 (2015).
Weischenfeldt, J. & Porse, B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008, pdb.prot5080 (2008).
Van Dyken, S. J. & Locksley, R. M. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu. Rev. Immunol. 31, 317–343 (2013).
Shapouri-Moghaddam, A. et al. Macrophage plasticity, polarization, and function in health and disease. J. Cell Physiol. 233, 6425–6440 (2018).
Mosser, D. M., Hamidzadeh, K. & Goncalves, R. Macrophages and the maintenance of homeostasis. Cell Mol. Immunol. 18, 579–587 (2021).
Rosas, M. et al. The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal. Science 344, 645–648 (2014).
Yu, X. et al. Identifying Prokineticin2 as a novel immunomodulatory factor in diagnosis and treatment of sepsis. Crit. Care Med. 50, 674–684 (2021).
Schreurs, R. et al. Human fetal TNF-α-cytokine-producing CD4(+) effector memory T cells promote intestinal development and mediate inflammation early in life. Immunity 50, 462–476.e8 (2019).
Egan, C. E. et al. Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. J. Clin. Invest. 126, 495–508 (2016).
Ma, F. et al. Melatonin ameliorates necrotizing enterocolitis by preventing Th17/Treg imbalance through activation of the AMPK/SIRT1 pathway. Theranostics 10, 7730–7746 (2020).
Parkhomchuk, D. et al. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res. 37, e123 (2009).
Arlauckas, S. P. et al. Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages. Theranostics 8, 5842–5854 (2018).
Corbin, A. L. et al. IRF5 guides monocytes toward an inflammatory CD11c macrophage phenotype and promotes intestinal inflammation. Sci. Immunol. 5, eaax6085 (2020).
Zhu, L. et al. TSC1 controls macrophage polarization to prevent inflammatory disease. Nat. Commun. 5, 4696 (2014).
Horbar, J. D. et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 129, 1019–1026 (2012).
Emami, C. N. et al. Role of neutrophils and macrophages in the pathogenesis of necrotizing enterocolitis caused by Cronobacter sakazakii. J. Surg. Res. 172, 18–28 (2012).
Gourlay, D. M. The good and the bad of the innate immune response in necrotizing enterocolitis. J. Surg. Res. 175, 51–53 (2012).
Li, C. et al. MicroRNA regulated macrophage activation in obesity. J. Transl. Int. Med. 7, 46–52 (2019).
Li, C. et al. AtheroSpectrum reveals novel macrophage foam cell gene signatures associated with atherosclerotic cardiovascular disease risk. Circulation 145, 206–218 (2022).
Pelisch, N. et al. CCL3 contributes to secondary damage after spinal cord injury. J. Neuroinflammation 17, 362 (2020).
Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Investig. 122, 787–795 (2012).
Na, Y. R. et al. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat. Rev. Gastroenterol. Hepatol. 16, 531–543 (2019).
Acknowledgements
We thank Dr Jinfeng Hou (Department of Gastrointestinal and Neonatal Surgery, Children’s Hospital of Chongqing Medical University) and Dr Xiaohong Die (Department of Gastrointestinal and Neonatal Surgery, Children’s Hospital of Chongqing Medical University) for clinical samples collection.
Funding
The study was supported, in part, by the National Natural Science Foundation of China (Grant Number: 81801956 to Z.S.), Chongqing Municipal Health Commission (Grant Number: 2020MSXM050 to D.C.), Chongqing Science and Technology Commission (Grant Number: cstc2019jcyj-msxmX0364 to H.T.), Distinguished Young Scholars of the Children’s Hospital of Chongqing Medical University (to Z.S.).
Author information
Authors and Affiliations
Contributions
Z.S. and D.C. conceived and designed the experiments. X.Y., W.L., Y.L., H.T. and H.L. performed the experiments. W.L. and Y.Y. collected and analyzed the data. Z.S. and X.Y. wrote of the manuscript. All authors reviewed and approved the final submitted and published versions.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was approved by the Ethics Committee of Children’s Hospital of Chongqing Medical University and the Animal Ethics Committee of Chongqing Medical University.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yuan, X., Liu, W., Li, Y. et al. CCL3 aggravates intestinal damage in NEC by promoting macrophage chemotaxis and M1 macrophage polarization. Pediatr Res 94, 119–128 (2023). https://doi.org/10.1038/s41390-022-02409-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-022-02409-w